What is Bio-options?
Bio-options is a specialized provider of high-quality human tissues and biological materials, catering to researchers and scientists engaged in molecular and genomic studies. The company maintains an extensive biorepository, offering a diverse array of sample types, including frozen and FFPE tissues, alongside blood samples. These critical biological resources are sourced through a wide network of community-based hospitals. As a physician-owned entity, Bio-options prioritizes a consultative approach, ensuring that the specific needs of research clients are met with expert oversight and efficient service delivery. Their client base comprises research scientists and institutions requiring dependable biospecimens for a variety of biomedical applications.
How much funding has Bio-options raised?
Bio-options has raised a total of $102K across 1 funding round:
Debt
$102K
Debt (2021): $102K with participation from PPP
Key Investors in Bio-options
PPP
Public-Private Partnership
What's next for Bio-options?
With its recent large-scale, late-stage funding, Bio-options is strategically positioned to expand its biorepository capabilities and enhance its service offerings. This capital infusion is expected to fuel advancements in sample acquisition, processing, and distribution, further solidifying its market leadership. The company's focus on providing high-quality biological materials for critical research, particularly in genomics and molecular studies, aligns with the growing demand for precision medicine and drug discovery. Future growth will likely involve deepening partnerships with healthcare institutions and research organizations, potentially exploring new sample types or analytical services to support the evolving landscape of biomedical research.
See full Bio-options company page
